Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1992 | 06-1992 | 03-1992 | 12-1991 | 06-1991 | |
| Operating Expenses | 322 | 0 | 178 | 790 | 0 |
| Operating Income | -322 | N/A | -178 | -790 | N/A |
| Other Income | 46 | 0 | 12 | 80 | 0 |
| Pre-tax Income | -276 | 0 | -166 | -710 | 0 |
| Net Income Continuous | -276 | N/A | -166 | -710 | N/A |
| Net Income | $-276 | $N/A | $-166 | $-710 | $N/A |
| EPS Basic Total Ops | -0.05 | N/A | -0.03 | -0.14 | N/A |
| EPS Basic Continuous Ops | -0.05 | N/A | -0.03 | -0.14 | N/A |
| EPS Diluted Total Ops | -0.05 | N/A | -0.03 | -0.14 | N/A |
| EPS Diluted Continuous Ops | -0.05 | N/A | -0.03 | -0.14 | N/A |
| EBITDA(a) | $-322 | $N/A | $-178 | $-790 | $N/A |